IPO registrations (S-1, F-1) · Registrants
Synergy CHC Corp.
- SEC CIK
- 1562733 · filings on EDGAR ↗
- Former names
- Synergy Strips Corp. (2014–2015); Oro Capital Corporation, Inc. (2012–2014)
- Registration
- Form S-1, first filed 2012-11-21, last 2026-05-15; 5 initial registrations, 15 amendments
- Outcome
- Final prospectus filed 2024-10-23; declared effective 2013-06-14; withdrawal requested 2022-10-18
- Industry (SIC)
- Medicinal Chemicals & Botanical Products 2833
- Incorporated in
- NV
- Business address
- 865 SPRING STREET, Westbrook, ME 04092
- EIN
- 99-0379440
- Ticker
- SNYRQ (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Synergy CHC Corp. on the corporate pages
On this site
- Form D issuer: Oro Capital Corporation, Inc. EXACT (CIK (EXACT))
- SEC filer: Synergy CHC Corp. EXACT (CIK (EXACT))
Filings 29
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2012-11-21 | S-1 | S-1 (registration) | Oro Capital Corporation, Inc. | 0001477932-12-004613 ↗ |
| 2013-02-19 | S-1/A | S-1/A (amendment) | Oro Capital Corporation, Inc. | 0001477932-13-000737 ↗ |
| 2013-04-30 | S-1/A | S-1/A (amendment) | Oro Capital Corporation, Inc. | 0001477932-13-002046 ↗ |
| 2013-05-17 | S-1/A | S-1/A (amendment) | Oro Capital Corporation, Inc. | 0001117768-13-000289 ↗ |
| 2013-05-28 | S-1/A | S-1/A (amendment) | Oro Capital Corporation, Inc. | 0001117768-13-000312 ↗ |
| 2013-06-14 | S-1/A | S-1/A (amendment) | Oro Capital Corporation, Inc. | 0001117768-13-000328 ↗ |
| 2013-06-14 | EFFECT | EFFECT (declared effective) | Oro Capital Corporation, Inc. | 9999999995-13-001801 ↗ |
| 2021-10-22 | S-1 | S-1 (registration) | Synergy CHC Corp. | 0001493152-21-026094 ↗ |
| 2021-11-04 | S-1/A | S-1/A (amendment) | Synergy CHC Corp. | 0001493152-21-027171 ↗ |
| 2021-12-15 | S-1/A | S-1/A (amendment) | Synergy CHC Corp. | 0001493152-21-031478 ↗ |
| 2022-01-05 | S-1/A | S-1/A (amendment) | Synergy CHC Corp. | 0001493152-22-000334 ↗ |
| 2022-10-18 | RW | RW (withdrawal request) | Synergy CHC Corp. | 0001213900-22-064697 ↗ |
| 2024-06-28 | S-1 | S-1 (registration) | Synergy CHC Corp. | 0001213900-24-056991 ↗ |
| 2024-07-29 | S-1/A | S-1/A (amendment) | Synergy CHC Corp. | 0001013762-24-002165 ↗ |
| 2024-08-14 | S-1/A | S-1/A (amendment) | Synergy CHC Corp. | 0001213900-24-068424 ↗ |
| 2024-08-28 | S-1/A | S-1/A (amendment) | Synergy CHC Corp. | 0001213900-24-073419 ↗ |
| 2024-09-09 | S-1/A | S-1/A (amendment) | Synergy CHC Corp. | 0001213900-24-076929 ↗ |
| 2024-09-16 | S-1/A | S-1/A (amendment) | Synergy CHC Corp. | 0001213900-24-079034 ↗ |
| 2024-10-10 | S-1/A | S-1/A (amendment) | Synergy CHC Corp. | 0001213900-24-086889 ↗ |
| 2024-10-15 | S-1/A | S-1/A (amendment) | Synergy CHC Corp. | 0001213900-24-087398 ↗ |
| 2024-10-22 | S-1MEF | S-1MEF (added securities) | Synergy CHC Corp. | 0001213900-24-089733 ↗ |
| 2024-10-22 | EFFECT | EFFECT (declared effective) | Synergy CHC Corp. | 9999999995-24-003235 ↗ |
| 2024-10-23 | 424B4 | 424B4 (final prospectus) | Synergy CHC Corp. | 0001213900-24-089987 ↗ |
| 2025-08-15 | S-1 | S-1 (registration) | Synergy CHC Corp. | 0001213900-25-077458 ↗ |
| 2025-08-25 | EFFECT | EFFECT (declared effective) | Synergy CHC Corp. | 9999999995-25-002739 ↗ |
| 2025-08-26 | 424B4 | 424B4 (final prospectus) | Synergy CHC Corp. | 0001213900-25-080764 ↗ |
| 2025-12-09 | EFFECT | EFFECT (declared effective) | Synergy CHC Corp. | 9999999995-25-003617 ↗ |
| 2026-05-15 | S-1 | S-1 (registration) | Synergy CHC Corp. | 0001213900-26-057939 ↗ |
| 2026-05-22 | EFFECT | EFFECT (declared effective) | Synergy CHC Corp. | 9999999995-26-001752 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Knight Therapeutics (Barbados) Inc. | TenPercentOwner | 5 | 2015–2024 | ||
| FRYER STEPHEN J | Director | 2 | 2015 | ||
| Ross Jack | Director,Officer; Director,Officer,TenPercentOwner | CEO and Chairman; President and CEO; President & CEO; President, CEO and CFO | 18 | 2015–2026 | |
| SoRelle James Paul | Director | 3 | 2015–2024 | ||
| Gowan Private Equity Inc. | TenPercentOwner | 2 | 2015 | ||
| Bensussen Gale K. | Director | 1 | 2017 | ||
| Kadanoff Jeffrey | Officer | Chief Financial Officer | 1 | 2017 | |
| McCullough Patrick S. | Officer | President | 1 | 2017 | |
| Baumeler Alfred | Director,Officer | President | 3 | 2024–2026 | |
| Fickett Jaime | Officer | Chief Financial Officer; Senior VP Finance & Operations | 3 | 2024–2026 | |
| Kaushal Nitin | Director | 2 | 2024–2026 | ||
| Knight Therapeutics Inc | TenPercentOwner | 2 | 2024–2025 | ||
| McLaughlin Stacy B. | Officer | Chief Financial Officer | 1 | 2024 | |
| Woodburn Scott | Director | 1 | 2024 | ||
| Thompson Teresa Brigid | Director | 2 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2014-04-24 | Oro Capital Corporation, Inc. | Other | $4,000,000 | $4,000,000 | 32 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.